
Chandrakant Thakorbhai Kapadia
About Chandrakant Thakorbhai Kapadia
Data last updated:
Chandrakant Thakorbhai Kapadia is a Designated Partner at Niskrti Pharma Llp (since 2018). The companies operate in Aquaculture. Earlier, Chandrakant Thakorbhai Kapadia was a Director at Vision Healthline Private Limited (from 2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 19 Jan 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Jul 2011 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chandrakant Thakorbhai Kapadia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Darshil Bharatbhai Shah | 11356922 | Niskrti Pharma Llp | Designated Partner |
| Sarla Chandrakant Kapadia | 03639416 | Niskrti Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrakant Thakorbhai Kapadia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrakant Thakorbhai Kapadia
Chandrakant Thakorbhai Kapadia currently holds 1 directorship: Niskrti Pharma Llp (Designated Partner, since 19 Jan 2018).
Chandrakant Thakorbhai Kapadia was first appointed on 21 Jul 2011 as Director at Vision Healthline Private Limited. The most recent appointment on record is 19 Jan 2018 at Niskrti Pharma Llp.
Chandrakant Thakorbhai Kapadia held 1 earlier board appointment: Vision Healthline Private Limited (Director, from 21 Jul 2011).
The current boards of Chandrakant Thakorbhai Kapadia's companies include Darshil Bharatbhai Shah (Niskrti Pharma Llp), Sarla Chandrakant Kapadia (Niskrti Pharma Llp).